APAC’s Diversity A Key Challenge But Demand Will Keep Growing, says APACMed CEO
This article was originally published in Clinica
Asia Pacific has been pegged for some time by medtech companies as a lucrative market with big growth opportunities. But the region is far from being a single homogenous market and its diversity continues to present significant challenges to both large and small players. Tina Tan speaks to Fredrik Nyberg, CEO of the recently established Asia Pacific Medical Technology Association, APACMed, to find out more about the concerns he hears from companies; what APACMed’s plans are to help address these issues; and his perspective on how the land lies for those wanting to operate in this region
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.